|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Ezetimibe]] |
| {{Ezetimibe}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Dosage and Administration==
| |
| | |
| ===General Dosing Information===
| |
| | |
| The recommended dose of ZETIA is 10 mg once daily.
| |
| | |
| ZETIA can be administered with or without food.
| |
| | |
| ===Concomitant Lipid-Lowering Therapy===
| |
| | |
| ZETIA may be administered with a [[statin]] (in patients with primary [[hyperlipidemia]]) or with fenofibrate (in patients with mixed [[hyperlipidemia]]) for incremental effect. For convenience, the daily dose of ZETIA may be taken at the same time as the [[statin]] or fenofibrate, according to the dosing recommendations for the respective medications.
| |
| | |
| ===Coadministration with bile acid Sequestrants===
| |
| | |
| Dosing of ZETIA should occur either ≥2 hours before or ≥4 hours after administration of a [[bile acid]] sequestrant [see Drug Interactions (7.4)].
| |
| | |
| ===Patients with Hepatic Impairment===
| |
| | |
| No dosage adjustment is necessary in patients with mild hepatic impairment [see Warnings and Precautions (5.4)].
| |
| | |
| ===Patients with Renal Impairment===
| |
| | |
| No dosage adjustment is necessary in patients with [[renal impairment]] [see Clinical Pharmacology (12.3)]. When given with simva[[statin]] in patients with moderate to severe renal impairment (estimated glomerular filtration rate <60 mL/min/1.73 m2), doses of simva[[statin]] exceeding 20 mg should be used with caution and close monitoring [seeUse in Specific Populations (8.6)].
| |
| | |
| ===Geriatric Patients===
| |
| | |
| No dosage adjustment is necessary in geriatric patients [see Clinical Pharmacology (12.3)].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZETIA (EZETIMIBE) TABLET [MERCK SHARP & DOHME CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a773b0b2-d31c-4ff4-b9e8-1eb2d3a4d62a | publisher = | date = | accessdate = 11 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Hypolipidemic agents]]
| |
| [[Category:Lactams]]
| |
| [[Category:Merck]]
| |
| [[Category:Schering-Plough]]
| |
| [[Category:Azetidines]]
| |
| [[Category:Organofluorides]]
| |
| [[Category:Phenols]]
| |
| [[Category:Cardiovasuclar Drugs]]
| |
| [[Category:Drugs]]
| |